← Back to Search

Vitamin

Folic Acid supplementation for Folate

N/A
Waitlist Available
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights

Summary

This trial involves giving healthy participants multivitamins with different amounts of folic acid. Researchers aim to see how this affects folate absorption and protein activity in the colon. The goal is to better understand folate metabolism and improve dietary recommendations.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Colonic folate levels
Secondary study objectives
GCPII
GGH
PCFT
+1 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Folic Acid supplementationActive Control2 Interventions
Participants receive an adult multivitamin supplement along with a folic acid supplement
Group II: No supplementationPlacebo Group1 Intervention
Participants only receive an adult multivitamin supplement

Find a Location

Who is running the clinical trial?

The Hospital for Sick ChildrenLead Sponsor
704 Previous Clinical Trials
6,956,853 Total Patients Enrolled
Natural Sciences and Engineering Research Council, CanadaOTHER
60 Previous Clinical Trials
3,144 Total Patients Enrolled

Media Library

Adult Multivitamin (Vitamin) Clinical Trial Eligibility Overview. Trial Name: NCT03421483 — N/A
Folate Research Study Groups: Folic Acid supplementation, No supplementation
Folate Clinical Trial 2023: Adult Multivitamin Highlights & Side Effects. Trial Name: NCT03421483 — N/A
Adult Multivitamin (Vitamin) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03421483 — N/A
~4 spots leftby Oct 2025